The PUMA‐mediated tumour suppression by gilteritinib was examined by injecting nude mice subcutaneously with WT and PUMA‐KO HCT116 cells to establish xenograft tumours and was then treated with 5 mg/kg gilteritinib or the control vehicle and the tumours were observed. The gene discussed is BBC3; the disease is neoplasm.